Drug & intervention

Fiasp

RxCUI 1986350

Clinical trials5

Recruiting0

Related conditions4

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

5 shown

A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 DiabetesNCT05199714 · 2022-02-21

AT247, NovoLog® and Fiasp® Administered Via Continuous Subcutaneous Infusion in Glucose Clamp StudyNCT05184868 · 2022-01-03

Fast Advanced Closed-Loop TherapyNCT04853030 · 2021-04-06

Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial PancreasNCT04163874 · 2020-02-14

Evaluation of Fiasp® (Fast Acting Insulin Aspart) in 670G Hybrid Closed-Loop TherapyNCT03554486 · 2018-07-23

Conditions being studied

Type 1 Diabetes3 Diabetes Mellitus, Type 12 Hyperglycemia, Postprandial1 Type 1 Diabetes Mellitus1

Research locations

MontrealQuebec, Canada2 Chula VistaCalifornia, United States1 GrazAustria1 Palo AltoCalifornia, United States1

Leading sponsors

Arecor Limited1 McGill University1 McGill University Health Centre/Research Institute of the McGill University Health Centre1 Stanford University1 University of Ljubljana, Faculty of Medicine1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.